The drug is a fusion protein comprising the human interleukin (IL)-1 type 1 receptor ... drugs including Kinaret (anakinra), an IL-1 receptor antagonist approved to treat rheumatoid arthritis ...

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

Researchers from Fujita Health University School of Medicine, and Nagoya University Graduate School of Medicine, Japan, studied the role of interleukin-36 (IL-36) receptor antagonist in wound ...